Concomitant low dose-rate irradiation and cis platin treatment in ovarian carcinoma cell lines sensitive and resistant to cis platin treatment-Reference-Cited by-同舟云学术

Concomitant low dose-rate irradiation and cis platin treatment in ovarian carcinoma cell lines sensitive and resistant to cis platin treatment

Published:1996-01-01 Issue:5 Volume:69 Page:623-631
ISSN:0955-3002
Container-title:International Journal of Radiation Biology
language:en
Short-container-title:International Journal of Radiation Biology

Author:

RAAPHORST G. P.¹

Affiliation:

1. Medical Physics Department, Civic Division, Ottawa Regional Cancer Center, 190 Melrose, Ottawa, Ontario, Canada K1Y 4K7.

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

https://www.tandfonline.com/doi/pdf/10.1080/095530096145634

Reference37 articles.

1. Cisplatin and radiation: Interaction probabilities and therapeutic possibilities

2. BEGG, A. C., VAN DER KOLL P. L., DEWIT and BARTELINK, H. 1986, Radiosensitization by cisplatin of RIF1 tumour cells in vitro. InternationalJournal of Radiation Oncology, 50, 871–884.

3. BRITTEN, R. A., WARENIUS, H. M., CARRAWAY, A. V. AND MURRAY D. 1994, Differential modulation of radiosensitivity fol-lowing induction of cisplatin resistance in radiation-sensitive and radiation-resistant human cells. Radiation Oncology Investigations, 2, 25–31.

4. Effect of cis-dichlorodiammine platinum IIand X rays on mammalian cell survival

5. Platinum based combined modality approach for locally advanced head and neck carcinoma

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Composition of Conditioned Media from Radioresistant and Chemoresistant Cancer Cells Reveals miRNA and Other Secretory Factors Implicated in the Development of Resistance;International Journal of Molecular Sciences;2023-11-19

2. Determining optimal eluter design by modeling physical dose enhancement in brachytherapy;Medical Physics;2018-07-10

3. Experience of weekly cisplatin concurrent with intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma patients with resistance to neoadjuvant chemotherapy;Medicine;2017-11

4. Significant Radiation Enhancement Effects by Gold Nanoparticles in Combination with Cisplatin in Triple Negative Breast Cancer Cells and Tumor Xenografts;Radiation Research;2017-02

5. Complex Cisplatin-Double Strand Break (DSB) Lesions Directly Impair Cellular Non-Homologous End-Joining (NHEJ) Independent of Downstream Damage Response (DDR) Pathways;Journal of Biological Chemistry;2012-07